Barrington analyst Alexander Paris reiterated a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $112.00. The ...

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended January 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key ...

During the third quarter of fiscal 2025, despite inflationary challenges, HealthEquity experienced solid growth in HSA balances, driven by a significant increase in invested assets, which now ...

We came across a bullish thesis on HealthEquity, Inc. (HQY) on Substack by Francesco Ferrari. In this article, we will ...

Keybank National Association OH bought a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the 4th quarter, ...

The HealthEquity Community Foundation today announced the first recipients of grants from their inaugural grant cycle, and the application timeline for their next grant cycle. This marks a significant ...

The Wasatch Small Cap Growth Fund—Investor Class gained 5.50% and outperformed the benchmark Russell 2000® Growth Index, ...

Wasatch Core Growth Fund—Investor Class gained 0.76% but underperformed the benchmark Russell 2000® Growth Index, which was ...

HealthEquity HQY has outperformed the market over the past 10 years by 4.96% on an annualized basis producing an average ...

Wavestone announces share buy-back program, repurchasing 12,376 shares at €47.80-€48.20 from February 24-28, 2025 on Euronext Paris ...

HealthEquity (NASDAQ:HQY – Get Free Report) had its price target upped by stock analysts at Wells Fargo & Company from $110.00 to $125.00 in a research report issued on Wednesday,Benzinga reports. The ...

Highlights,HealthEquity has received multiple target price adjustments from major financial firms.,Institutional investors maintain significant holdings in the company.,Recent stockholder transactions ...